Testing a new drug called PHST001 in adults with advanced solid tumors
Original title: A Study of PHST001 in Advanced Solid Tumors
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This is a first safety test of the drug in people.
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study is testing whether a new drug, PHST001, is safe for adults whose cancer has come back or kept growing.
Who this trial is for. This study is for adults with advanced solid tumors that came back or did not respond to earlier treatment. Some brain and spinal cord tumors are included in the first part. The study tests PHST001 on its own, and later tests it together with chemotherapy.
Where it stands. There are no results yet. The study has not reported results. The team is watching how safe the drug is and how well people handle it. They are also working out the right dose to carry forward, and looking at what the drug does to tumors when it is given with chemotherapy.
What this means, and what it doesn't
What it could mean: This is an early look at a drug that has not been tested in people before. It is not treatment you can get from your own doctor. If your situation sounds like the one described here, you can ask your care team whether a study like this is worth looking into.
What it doesn't mean: This does not mean PHST001 works. A trial is a test, not a proven treatment. Joining a study is not a guarantee that it will help you, and it may not. Some people have side effects. This is not a cure, and no one can promise it will become one.
Source: ClinicalTrials.gov, August 12, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.